What is the initial workup for a patient suspected of having pemphigus vulgaris?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for Pemphigus Vulgaris

The initial workup for suspected pemphigus vulgaris must include skin/mucosal biopsies for both routine histopathology and direct immunofluorescence (DIF), along with serum testing for autoantibodies. 1

Diagnostic Biopsies

Skin/Mucosal Biopsy Collection

  • Lesional biopsy for histopathology:

    • Take from a fresh, intact blister or erosion
    • Look for suprabasal acantholysis and intraepithelial blister formation 1
  • Perilesional biopsy for DIF:

    • Take from clinically normal-appearing skin/mucosa approximately 1 cm away from lesion 1, 2
    • For oral pemphigus, buccal mucosa is the optimal site 2
    • Never take DIF biopsy from lesional skin as it reduces diagnostic accuracy 2

Biopsy Transport

  • Transport medium for DIF:
    • Normal saline (0.9% NaCl) is optimal for transport times ≤24 hours 2
    • Michel's medium preferred for longer transportation times 1
    • Saline provides superior results by washing away non-specific IgG, reducing background interference 2

Serological Testing

  • Indirect immunofluorescence (IIF):

    • Use both mucosal substrate (monkey esophagus) and skin substrate for optimal detection 1
    • Mucosal substrates better detect desmoglein 3 antibodies
    • Skin substrates better detect desmoglein 1 antibodies 1
  • Enzyme-linked immunosorbent assay (ELISA):

    • Direct measurement of anti-desmoglein 1 and 3 antibodies
    • More sensitive and specific than IIF 1
    • Helpful for disease monitoring 1

Additional Baseline Investigations

Before initiating treatment, obtain the following 1:

  • Laboratory tests:

    • Complete blood count and differential
    • Renal function (urea and electrolytes)
    • Liver function tests
    • Fasting glucose and HbA1c
    • Fasting lipids
    • Antinuclear antibody (to rule out pemphigus erythematosus)
    • Pregnancy test in women of childbearing age
  • Other assessments:

    • Blood pressure measurement
    • Weight
    • Height (in children)
    • Consider bone density scan if systemic corticosteroid therapy is planned
    • Consider ocular examination (for ocular tension and cataract) if long-term systemic corticosteroid therapy is planned

Special Considerations

  • If oral pemphigus is suspected:

    • Intraoral biopsy is optimal but DIF on skin biopsy may suffice
    • DIF sensitivity is 71-89% in oral biopsies versus 61-85% for normal skin in patients with oral PV 1
  • If biopsy is difficult (children, uncooperative adults):

    • IIF or ELISA may be helpful as alternative diagnostic methods 1
  • Pre-treatment screening if immunosuppression is planned:

    • Serology for hepatitis B, hepatitis C, and HIV
    • Consider tuberculosis screening
    • Consider appropriate vaccinations before immunosuppression 1

Common Pitfalls to Avoid

  1. Improper biopsy site selection: Taking DIF from lesional rather than perilesional tissue significantly reduces diagnostic accuracy 2

  2. Delayed transport of DIF specimens: Diagnostic accuracy decreases with increased transport time, especially in saline medium 2

  3. Using only one diagnostic method: Relying solely on histopathology, DIF, or serology may lead to missed diagnoses; combining methods increases diagnostic accuracy 1

  4. Failure to consider drug-induced pemphigus: Always take a thorough drug history as certain medications can trigger pemphigus that mimics idiopathic disease 1

  5. Inadequate baseline investigations: Failing to obtain comprehensive baseline tests before initiating treatment may lead to complications during therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Direct Immunofluorescence in Autoimmune Bullous Diseases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.